Molecular PET and immuno-PET in gastric cancer immunotherapy: current evidence, clinical utilities, and translational barriers
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is being conducted on the use of molecular pet and immuno-pet in gastric cancer immunotherapy, exploring its current evidence, clinical utilities, and translational barriers. Studies are investigating various aspects of this topic, including targeted pet imaging and the role of immune checkpoint molecules in cancers. The field of cancer immunotherapy is also seeing advancements in related areas, such as new imaging techniques and radiopharmaceutical applications.
Full coverage
12345678